Optimal vaccine allocation for the control of sexually transmitted infections

Author:

Saldaña Fernando1ORCID,Steindorf Vanessa1,Srivas Akhil1,Stollenwerk Nico2,Aguiar Maíra1

Affiliation:

1. Basque Center for Applied Mathematics: Centro Vasco de Matematicas Aplicadas

2. University of Trento: Universita degli Studi di Trento

Abstract

Abstract The burden of sexually transmitted infections (STIs) poses a challenge due to its large negative impact on sexual and reproductive health worldwide. Besides simple prevention measures and available treatment efforts, prophylactic vaccination is a powerful tool for controlling some viral STIs and their associated diseases.Here, we investigate how prophylactic vaccines are best distributed to prevent and control STIs. We consider sex-specific differences in susceptibility to infection, as well as disease severity outcomes.Different vaccination strategies are compared assuming distinct budget constraints that mimic a scarce vaccine stockpile. Vaccination strategies are obtained as solutions to an optimal control problem subject to a two-sex Kermack-McKendrick-type model, where the control variables are the daily vaccination rates for females and males.One important aspect of our approach relies on conceptualizing a limited but specific vaccine stockpile via an isoperimetric constraint. We solve the optimal control problem via Pontryagin's Maximum Principle and obtain a numerical approximation for the solution using a modified version of the forward-backward sweep method that handles the isoperimetric budget constraint in our formulation. The results suggest that for a limited vaccine supply (\(20%-30%\) vaccination coverage), one-sex vaccination, prioritizing females, appears to be more beneficial than the inclusion of both sexes into the vaccination program. Whereas, if the vaccine supply is relatively large (enough to reach at least \(40%\) coverage), vaccinating both sexes, with a slightly higher rate for females, is optimal and provides an effective and faster approach to reducing the prevalence of the infection. MSC Classi cation: 92B05 , 49N90 , 34A34

Publisher

Research Square Platform LLC

Reference75 articles.

1. Angioli, Roberto and Lopez, Salvatore and Aloisi, Alessia and Terranova, Corrado and De Cicco, Carlo and Scaletta, Giuseppe and Capriglione, Stella and Miranda, Andrea and Luvero, Daniela and Ricciardi, Roberto and others (2016) Ten years of HPV vaccines: State of art and controversies. Critical reviews in oncology/hematology 102: 65--72 https://doi.org/https://doi.org/10.1016/j.critrevonc.2016.03.020, Elsevier

2. Brisson, Marc and Kim, Jane J and Canfell, Karen and Drolet, M{\'e}lanie and Gingras, Guillaume and Burger, Emily A and Martin, Dave and Simms, Kate T and B{\'e}nard, {\'E}lodie and Boily, Marie-Claude and others (2020) Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet 395(10224): 575--590 https://doi.org/https://doi.org/10.1016/S0140-6736(20)30068-4, Elsevier

3. Bogaards, Johannes A and Kretzschmar, Mirjam and Xiridou, Maria and Meijer, Chris JLM and Berkhof, Johannes and Wallinga, Jacco (2011) Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS medicine 8(12): e1001147 https://doi.org/https://doi.org/10.1371/journal.pmed.1001147, Public Library of Science

4. Bogaards, Johannes A and Wallinga, Jacco and Brakenhoff, Ruud H and Meijer, Chris JLM and Berkhof, Johannes (2015) Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ 350: h2016 https://doi.org/https://doi.org/10.1136/bmj.h2016, British Medical Journal Publishing Group

5. Brown, Victoria L and White, KA Jane (2011) The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study. Mathematical Biosciences 231(2): 126--134 https://doi.org/https://doi.org/10.1016/j.mbs.2011.02.009, Elsevier

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3